An evaluation of the impact of NICE guidance on GP prescribing

British Journal of General Practice

Volumn 54, Issue 499, 2004, Pages 103-107

  Wathen, Bernard ^a   Dean, Tara ^b  

^a NORTH DEVON DISTRICT HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Clinical practice guidelines; Prescription, drug; Primary health care; Technology assessment

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; INFLUENZA VACCINE; PROTON PUMP INHIBITOR; ROSIGLITAZONE; TETRAHYDROLIPSTATIN; TROGLITAZONE; ZANAMIVIR;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL PRACTICE; DATA ANALYSIS; DIET THERAPY; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; INFLUENZA; INTERVIEW; LIVER TOXICITY; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; OBESITY; PHYSICAL ACTIVITY; PHYSICIAN ATTITUDE; POSTAL MAIL; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SIDE EFFECT;

ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; GREAT BRITAIN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0442325411     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. National Institute for Clinical Excellence: About NICE - Background. http://www.nice.org.uk/cat.asp?c=137 (accessed 5 Jan 2004).
2. National Institute for Clinical Excellence: About NICE - Why has NICE been set up? http://www.nice.org.uk/article.asp?a=256 (accessed 5 Jan 2004).
3. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations. Lancet 1993; 342: 1317-1322.
4. NHS Centre for Reviews and Dissemination. Implementing clinical practice guidelines. Effective Health Care 1994; 1(8): 1-12.
5. Freemantle N, Harvey EL, Wolf F, et al. Printed educational materials: Effects on professional practice and health care outcomes. In: Cochrane Collaboration. Cochrane Library. Issue 2. Oxford: Update Software, 2000. [Currently withdrawn by the Cochrane editorial group.]
6. National Institute for Clinical Excellence. Technology appraisal guidance no. 7. Guidance on the use of proton pump inhibitors in the treatment of dyspepsia. London: National Institute for Clinical Excellence, 2000. http://www.nice.org.uk/pdf/proton.pdf (accessed 18 Dec 2003).
7. National Institute for Clinical Excellence. Technology appraisal no. 9. Guidance on rosiglitazone for type 2 diabetes mellitus. London: National Institute for Clinical Excellence, 2000. http://www.nice.org.uk/pdf/rosiglitazoneguidance.pdf (accessed 18 Dec 2003).
8. National Institute for Clinical Excellence. Technology appraisal guidance no. 15. Guidance on the use of zanamivir (Relenza) in the treatment of influenza. London: National Institute for Clinical Excellence, 2000. [Obsolete, replaced by no. 58.] http://www.nice.org.uk/cat.asp?c=426 (accessed 18 Dec 2003).
9. National Institute for Clinical Excellence. Technology appraisal guidance no. 22. Guidance on the use of orlistat for the treatment of obesity in adults. London: National Institute for Clinical Excellence, 2001. http://www.nice.org.uk/pdf/orlistatguidance.pdf (accessed 18 Dec 2003).
10. National Institute for Clinical Excellence. Technology appraisal guidance no. 27. Guidance on cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis. London: National Institute for Clinical Excellence, 2001. http://www.nice.org.uk/pdf/coxiifullguidance.pdf (accessed 18 Dec 2003).
11. Hill S, Garattine S, Van Loenhout J, et al. Technology Appraisal Programme of the National Institute of Clinical Excellence - A review by WHO. Geneva: World Health Organisation, 2003. http://www.nice.org.uk/pdf/boardmeeting/brdsep03itemtabled.pdf (accessed 18 Dec 2003).